Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sameh Wajih"'
Autor:
Wael Al Mahmeed, Sherif Bakir, Salem A Beshyah, Bassem Morcos, Sameh Wajih, Martin Horack, Dominik Lautsch, Baishali Ambegaonkar, Philippe Brudi, Carl A Baxter, Ami Vyas, Anselm K Gitt
Publikováno v:
Heart Views, Vol 20, Iss 2, Pp 37-46 (2019)
Background: Careful management of lipid abnormalities in patients with coronary heart disease (CHD) or an acute coronary syndrome (ACS) can reduce the risk of recurrent cardiovascular events. The extent of hyperlipidemia in these very high-risk patie
Externí odkaz:
https://doaj.org/article/6f70125cea474dc4b4b2bf07d1a93688
Autor:
Mohamed Sobhy, Adel El Etriby, Amany El Nashar, Sameh Wajih, Martin Horack, Philippe Brudi, Dominik Lautsch, Baishali Ambegaonkar, Ami Vyas, Anselm K. Gitt
Publikováno v:
The Egyptian Heart Journal, Vol 70, Iss 3, Pp 129-134 (2018)
Background: Effective management of hyperlipidemia is of utmost importance for prevention of recurring cardiovascular events after an acute coronary syndrome (ACS). Indeed, guidelines recommend a low-density lipoprotein cholesterol (LDL-C) level of
Externí odkaz:
https://doaj.org/article/375d8b5c13d34fb781949ab4416a4ed6
Autor:
Saud N Al Sifri, Wael Almahmeed, Sami Azar, Osama Okkeh, Peter Bramlage, Claus Jünger, Islam Halawa, Baishali Ambegaonkar, Sameh Wajih, Philippe Brudi
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e84350 (2014)
BACKGROUND: Therapeutic intervention with low-density lipoprotein cholesterol-lowering agents known as statins has been demonstrated to reduce cardiovascular risk. However, many patients on statin treatment have persistent dyslipidemia and remain at
Externí odkaz:
https://doaj.org/article/87624088cb7f4a6e9e0f71d3271e17df
Autor:
Amany El Nashar, Dominik Lautsch, Sameh Wajih, Philippe Brudi, Mohamed Sobhy, Martin Horack, Adel El Etriby, Anselm K. Gitt, Baishali M. Ambegaonkar, Ami Vyas
Publikováno v:
The Egyptian Heart Journal, Vol 70, Iss 3, Pp 129-134 (2018)
The Egyptian Heart Journal
The Egyptian Heart Journal
Background: Effective management of hyperlipidemia is of utmost importance for prevention of recurring cardiovascular events after an acute coronary syndrome (ACS). Indeed, guidelines recommend a low-density lipoprotein cholesterol (LDL-C) level of
Autor:
Bassem Morcos, Abdullah H. Alkhenizan, Sameh Wajih, Anselm K. Gitt, Baishali M. Ambegaonkar, Dominik Lautsch, Atif Bin Shafi Shafiurrehman, Saud Al Sifri, Martin Horack, Phillippe Brudi, Ibrahim Elnahal, Ami Vyas, Saleh Al Jaser, Owayed Al Shammeri, Carl A. Baxter
Publikováno v:
Saudi Medical Journal, Vol 39, Iss 7, Pp 697-704 (2018)
Objectives: To provide an overview of the extent of hyperlipidemia in very high-risk patients, and how lipid-lowering therapy (LLT) is used in a real-world setting. Methods : In this multicenter observational study, data were collected from LLT-treat
Autor:
Dominik Lautsch, Wael Al Mahmeed, Carl A. Baxter, Philippe Brudi, Sameh Wajih, Bassem Morcos, Salem A Beshyah, Ami Vyas, Sherif Bakir, Martin Horack, Anselm K. Gitt, Baishali M. Ambegaonkar
Publikováno v:
Heart Views, Vol 20, Iss 2, Pp 37-46 (2019)
Heart Views : The Official Journal of the Gulf Heart Association
Heart Views : The Official Journal of the Gulf Heart Association
Background: Careful management of lipid abnormalities in patients with coronary heart disease (CHD) or an acute coronary syndrome (ACS) can reduce the risk of recurrent cardiovascular events. The extent of hyperlipidemia in these very high-risk patie
Autor:
Anselm K. Gitt, Baishali M. Ambegaonkar, Sherif Bakir, Sameh Wajih, Veronica Ashton, Martin Horack, Afzalhussein Yusufali, Philippe Brudi, Wael Al Mahmeed
Publikováno v:
Global Heart. 10:e24
Autor:
Baishali M. Ambegaonkar, Sameh Wajih, Saud Al Sifri, Osama Okkeh, Philippe Brudi, Wael Almahmeed, Sami T. Azar, Islam Halawa, Peter Bramlage, Claus Jünger
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e84350 (2014)
PLoS ONE
PLoS ONE
BACKGROUND: Therapeutic intervention with low-density lipoprotein cholesterol-lowering agents known as statins has been demonstrated to reduce cardiovascular risk. However, many patients on statin treatment have persistent dyslipidemia and remain at